Chemical Computing Group Acquires Discngine

ICIS (RELX) Acquires Chemical Data (CDI)

July 13, 2020

Data & Analytics

ICIS, a division of RELX, has acquired Chemical Data, LLC (CDI), a Houston-based provider of US petrochemical price benchmarks, market analysis, and predictive analytics. The acquisition combines CDI's US petrochemical expertise with ICIS' existing global footprint to deliver expanded price benchmark coverage, forecasts and market intelligence to customers worldwide.

Tata Consulting Engineers Acquires CDI Engineering Solutions from AE Industrial Partners

January 8, 2025

Engineering Services

Tata Consulting Engineers (TCE) has completed the acquisition of CDI Engineering Solutions, a Houston-based multi-discipline EPCM and engineering firm, from private equity firm AE Industrial Partners. CDI, with 600+ employees and eight engineering centers, expands TCE's U.S. footprint and strengthens its capabilities in energy transition, semiconductors and advanced manufacturing.

Certara Acquires Chemaxon to Expand Drug Discovery Software Capabilities

July 9, 2024

Software

Certara, Inc. has signed a definitive agreement to acquire Chemaxon, a leading cheminformatics software provider, with the transaction expected to close in the second half of 2024, subject to regulatory approvals. The acquisition adds Chemaxon’s discovery-focused cheminformatics tools to Certara’s biosimulation portfolio, enabling a more comprehensive data and predictive-analytics platform spanning discovery through development.

Calibre Scientific Acquires Glass Chemicals

January 16, 2023

Healthcare Services

Calibre Scientific has acquired Glass Chemicals, a Spanish distributor of laboratory consumables, equipment and services, expanding Calibre's footprint across Spain including operations in Madrid and Barcelona. The deal strengthens Calibre Scientific's distribution and after‑sales service capabilities for life sciences, diagnostics, hospital and industrial laboratory customers in Spain.

X-Chem Acquires IntelliSyn and AviSyn to Expand Drug Discovery Services

January 26, 2021

Biotechnology

X-Chem, a portfolio company of GHO Capital, has acquired Montreal-based IntelliSyn and its US-based sister company AviSyn to extend its drug discovery offering into medicinal chemistry, custom synthesis and scale-up process chemistry. The deal integrates downstream hit validation and lead optimisation capabilities into X-Chem’s DNA-Encoded Library (DEL) platform, enabling a streamlined screen-to-lead service for pharma and biotech clients; financial terms were not disclosed.

Calibre Scientific Acquires DCS Innovative Diagnostik-Systeme (DCS)

June 19, 2024

Medical Devices

Calibre Scientific has acquired DCS Innovative Diagnostik-Systeme GmbH & Co. KG, a Hamburg-based supplier of antibodies, reagents, detection systems and automation equipment for immunohistochemistry. The acquisition expands Calibre Scientific's diagnostics product portfolio and strengthens its commercial coverage across the DACH region.